Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Amgen Inc (NASDAQ:AMGN)

175.41
Delayed Data
As of Dec 08
 0.00 / 0.00%
Today’s Change
138.83
Today|||52-Week Range
191.10
+19.97%
Year-to-Date
Deciphering Wall Street's Differing Views of Amgen
10:02am / TheStreet.com - Paid Partner Content
AbbVie/J&J's Imbruvica Succeeds in Combo Study with Rituxan
Dec 06 / Zacks.com - Paid Partner Content
Sanofi Begins Combo Studies on Multiple Myeloma Candidate
Dec 08 / Zacks.com - Paid Partner Content
Biotech Stock Roundup: FDA Nod for Amgen PCSK9 Inhibitor, Revance Up on RT002 Data
Dec 06 / Zacks.com - Paid Partner Content
Deciphering Amgen
Dec 08 / TheStreet.com - Paid Partner Content
AbbVie Psoriasis Candidate Succeeds in 4th Phase III Study
Dec 05 / Zacks.com - Paid Partner Content
Dec. 7 Forum Update: 'Retail Sector' Edition
Dec 07 / GuruFocus News - Paid Partner Content
Mylan Up on FDA Approval & Amazon's Rumored Pharmacy Interest
Dec 04 / Zacks.com - Paid Partner Content
Roche's Avastin Gets Full FDA Approval for Brain Cancer
Dec 06 / Zacks.com - Paid Partner Content
Amgen's PCSK9 Inhibitor Gets FDA Nod for Stroke Prevention
Dec 04 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close175.41
Today’s open174.43
Day’s range173.43 - 175.97
Volume3,336,250
Average volume (3 months)2,588,102
Market cap$127.3B
Dividend yield2.62%
Data as of 4:15pm ET, 12/08/2017

Growth & Valuation

Earnings growth (last year)+13.02%
Earnings growth (this year)+8.88%
Earnings growth (next 5 years)+4.17%
Revenue growth (last year)+6.31%
P/E ratio15.8
Price/Sales4.86
Price/Book4.33

Competitors

 Today’s
change
Today’s
% change
GILDGilead Sciences0.000.00%
BIIBBiogen0.000.00%
ILMNIllumina Inc0.000.00%
----
Data as of 4:00pm ET, 12/08/2017

Financials

Next reporting dateJanuary 25, 2018
EPS forecast (this quarter)$3.03
Annual revenue (last year)$22.7B
Annual profit (last year)$7.7B
Net profit margin34.04%

Profile

Sector
Health Technology
Industry
Biotechnology
Chairman &
Chief Executive Officer
Robert A. Bradway
Executive Vice President-
Operations
Esteban Santos
Corporate headquarters
Thousand Oaks, California

Forecasts